Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience. (Q38911553)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

arterial hypertension

1 reference

based on heuristic

inferred from title

Noha M El Husseiny

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Mervat M Mattar

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Mohammed Abdel Kader Morad

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Noha H Ali

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Doaa M El Demerdash

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

29 July 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Annals of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

95

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1611-1616

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Advances in understanding and management of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Cardiac involvement in patients with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Pulmonary hypertension in patients with chronic myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Unexplained pulmonary hypertension in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2765-0

21 January 2018

Identifiers

10.1007/S00277-016-2765-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468853%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38911553&oldid=1522380875"